Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


Detailed analysis focusing on non-endocrine cells and validation of identified markers for detecting non-endocrine subpopulations. (a) Newly classified cell populations by reference component analysis (RCA)…more Credit: Scientific Reports (2022). DOI: 10.1038/s41598-022-08753-5
https://medicalxpress.com/news/2022-04-safer-mass-production-endocrine-cells.html

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.